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Abstract: It has been generally accepted that tissue engineered constructs should closely 
resemble the in-vivo mechanical and structural properties of the tissues they are intended to 
replace. However, most scaffolds produced so far were isotropic porous scaffolds with 
non-characterized mechanical properties, different from those of the native healthy tissue. 
Tissues that are formed into these scaffolds are initially formed in the isotropic porous 
structure and since most tissues have significant anisotropic extracellular matrix 
components and concomitant mechanical properties, the formed tissues have no structural 
and functional relationships with the native tissues. The complete regeneration of tissues 
requires a second differentiation step after resorption of the isotropic scaffold. It is doubtful 
if the required plasticity for this remains present in already final differentiated tissue. It 
would be much more efficacious if the newly formed tissues in the scaffold could 
differentiate directly into the anisotropic organization of the native tissues. Therefore, 
anisotropic scaffolds that enable such a direct differentiation might be extremely helpful to 
realize this goal. Up to now, anisotropic scaffolds have been fabricated using modified 
conventional techniques, solid free-form fabrication techniques, and a few alternative 
methods. In this review we present the current status and discuss the procedures that are 
currently being used for anisotropic scaffold fabrication. 
Keywords: tissue engineering; scaffolds; anisotropy; solid free-form fabrication; 
musculoskeletal 
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1. Introduction 
Damage to the tissues of the musculoskeletal system often result in failure to repair or the formation 
of regenerated tissue of inferior mechanical quality. Tissue engineering (TE) and regenerative 
medicine (RM) apply the principles of biology, embryology and engineering to develop functional 
substitutes for these damaged tissues. TE and RM typically involve implanting cells, with or without 
stimulating growth factors, into some form of supporting structural device, the so-called scaffold. The 
cells are allowed to grow, differentiate, and produce new tissue with their own specific extracellular 
matrix (ECM). In time, the formed tissue should also replace the space occupied by the scaffold. After 
resorption of the scaffold, the tissue formed should remodel into tissue with a large resemblance to the 
native tissue. This can be before or after implantation into the patient. In some cases the in-vitro 
culture period can be omitted and the scaffold can replace the deceased tissue directly, utilizing the 
host’s own body as a ‘bioreactor’. Cell harvest, scaffold seeding and implantation can then be 
performed in a single surgical event [1]. Taking this approach one step further, the scaffolding material 
can be inserted without cells. In this case, regeneration relies totally on the recruitment of native cells 
into the implanted scaffold and the subsequent deposition of an ECM [2]. Another option is the 
incorporation of cells directly into the scaffold during the scaffold fabrication process [3]. No matter 
which strategy is used, the scaffold itself is critical to the success of the construct, and in most cases 
actively directs the behavior of the cells within the scaffold. 
Factors governing scaffold design are complex and include considerations of scaffold architecture, 
pore size and pore morphology, mechanical properties, surface properties, degradation speed, and 
degradation products. The scaffold architecture and surface properties should enhance initial cell 
attachment and allow efficacious seeding into the entire scaffold, or if this is difficult, migration into 
the scaffold. The scaffold should enhance the mass transfer of metabolites, provide sufficient space for 
remodeling of the newly formed tissue matrix and the development of vascularization. Furthermore, it 
must provide sufficient mechanical strength, particularly initially before the new tissue has matured 
into functional tissue. In other words, the scaffold degradation profile should be designed in a way it 
supports the construct during the remodeling process. Factors affecting the rate of remodeling include 
the type of tissue, and the anatomy and physiology of the host tissue. 
A variety of materials have been used to produce scaffolds for the replacement and repair of 
damaged or traumatized musculoskeletal tissues. These materials include metals, ceramics, natural and 
synthetic polymers, and their combinations. In this review we will focus only on polymers. Both 
natural and synthetic polymers have been studied for use as scaffold materials in both TE and RM. 
Natural polymeric scaffolds have been produced from processed ECM constituents, such as collagen, 
elastin or hyaluronic acid. Natural polymeric scaffolds may also be produced from polymers derived 
from plants (alginate) or insects (chitosan). The most frequently used synthetic polymers are 
poly(lactic acid) (PLA), poly(glycolic acid) (PGA), poly(lactic-co-glycolic acid) (PLGA), 
poly(caprolactone) (PCL) and copolymers of these materials [4-7]. Generally, these materials have 
been approved for human use by the Food and Drug Administration. In addition, their degradation 
rates can be tailored to match that of new tissue formation. PLA is more hydrophobic and less 
crystalline than PGA and degrades at a slower rate, while PCL degrades even slower. The degradation 
rate of the polymers can be easily controlled by altering the ratio of the different copolymers in the 
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formulation, by changing the chain-length of the monomers or by changing the cross-linking density 
[4,8]. In addition to degradation rate, certain physical characteristics of the scaffold must be considered 
when designing a substrate to be used in TE. In order to promote tissue growth, the scaffold must have 
a large surface area to allow cell attachment. This is usually done by creating highly porous scaffolds. 
In these foam-like scaffolds, the pores should be large enough and interconnected with each other to 
allow cells to penetrate deeply into the scaffold and to facilitate nutrient and waste exchange by cells 
deep inside the scaffold. Moreover, the scaffolds should have appropriate mechanical properties to 
provide temporary support within a specific application. These characteristics are often dependent on 
both polymer and method of scaffold fabrication. 
Several methods have been developed to create highly porous scaffolds, including particle leaching 
[9,10], gas (CO2) foaming [11], freeze-drying [12], thermal induced phase separation (TIPS) [13,14], 
liquid/liquid phase separation in combination with freeze extraction [15], electrospinning [16], and 
particle sintering [17,18]. Also combinations of these techniques have been described [19]. More 
sophisticated tissue engineered constructs may utilize polymer scaffolds as a delivery vehicle for cells 
or bioactive proteins. Recently, a new class of scaffolds has been described in which synthetic 
polymers have been coated or blended with natural polymers [20,21]. 
Although these conventionally produced scaffolds hold great promise and have been applied to 
engineer a variety of tissues with varying success, most are limited by some flaws, which restrict their 
scope of applications [22]. In addition, the processing methods offer little capability to precisely 
control pore size, pore geometry, pore interconnectivity, spatial distribution of pores, and construction 
of internal channels within the scaffold. 
The major limitation of the conventionally fabricated scaffolds is their isotropic nature. The tissue 
that is formed into the pores of an isotropic scaffold is a negative or mirror image of the scaffold itself, 
and since most tissue has significant anisotropic arranged extracellular matrix components and 
concomitant mechanical properties, the tissue formed has no structural and mechanical relationship 
with the native tissue [23]. For complete regeneration of the tissue a second differentiation step is 
needed during and after resorption of the isotropic scaffold. It is doubtful if such a plasticity can be 
expected from already final differentiated tissue. It would be much more efficacious if the newly 
formed tissues in the scaffold could differentiate directly into the anisotropic organization of native 
tissues. Anisotropic scaffolds with a porous, tubular or other structure, that enable direct differentiation 
into the native tissue configuration might be extremely helpful to realize this goal. 
The introduction of solid free-form (SFF) technologies have initiated the start of a new exiting and 
revolutionary era for scaffold design and production [22]. SFF techniques are computerized fabrication 
techniques that can produce highly complex, layer-by-layer build, three-dimensional physical objects, 
using data generated by computer aided design (CAD) systems or computer-based medical imaging 
modalities. The most promising techniques to generate scaffolds with a highly anisotropic pore 
structure are SFF technologies, such as 3D fiber deposition (3DF), fused deposition modeling (FDM), 
bioplotting, stereolithography (STL), and selective laser sintering (SLS), but also modified 
“conventional” techniques, such as modified thermal induced phase separation (modified TIPS) and 
electrospinning. In this review we will present the current status and discuss the procedures which are 
currently in use for anisotropic scaffold production. 
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2. Solid Free-Form Fabrication 
Solid free-form technologies, also commonly known as rapid prototyping (RP), are computer aided 
manufacturing (CAM) techniques that can rapidly produce highly complex three dimensional physical 
objects using data generated by computer aided design (CAD) programs, or converted from computer-
based medical imaging modalities, such as MRI and CT [24,25]. Unlike conventional computerized 
machining processes, which involve the removal of materials from a stock, SFF techniques use the 
underlying concept of layered manufacturing whereby three-dimensional objects are fabricated with 
layer-by-layer building via the processing of solid sheet, liquid or powder material stocks [22]. The 
flexibility and outstanding manufacturing capabilities of SFF have been employed for biomedical 
applications, such as production of scale replicas of human bones [26], body organs [27], and 
advanced customized drug delivery devices [28]. The direct utilization of CAD models as inputs for 
scaffold fabrication allows complex scaffold designs to be realized. Patient specific data and scaffold 
structural properties required for regenerating specific tissues can be incorporated into scaffold design 
via CAD. The application of CAD strategies in conjunction with SFF fabrication will allow scaffolds 
with highly uniform pore morphologies, unlimited range of pore sizes, porosities and complete pore 
interconnectivity to be realized with unprecedented accuracy and consistency for patient specific 
application [22]. In addition, SFF techniques employ a diverse range of processing conditions which 
include solvent and/or porogen free processes and processing at room temperature. Some SFF 
techniques allow pharmaceutical and biological agents to be incorporated into the scaffold during 
fabrication [28-30]. The utilization of CAD will also allow scaffolds with optimized mechanical and 
structural properties to be fabricated. The following sections will focus on SFF techniques that have 
been used for fabricating anisotropic scaffolds. 
2.1. 3D Fiber Deposition/Fused Deposition Modeling 
3D fiber deposition and FDM are similar techniques. The majority of 3DF/FDM techniques are 
nozzle-based systems. Polymers are thermally processed when they pass a nozzle and are deposited as 
a relatively thick fiber on a collector plate. After deposition on the collector plate, the fibers cool 
down, solidify and the scaffold is ready for use (Figure 1AB). Fiber diameter can be controlled by 
changing parameters, such as nozzle diameter, deposition speed, extrusion speed and viscosity of the 
polymer, and can range between 170-750 µm [31-33]. A wide range of polymers, including hydrogels, 
have been used in 3DF/FDM [34-37]. However, most of the produced scaffolds have an internal 
isotropic organization. Each successive layer is deposited under a different angle, creating a specific 
lay-down pattern [38,39]. Most used lay-down patterns are 0/90º, 0/45/90/135º and 0/60/120º. The 
compressive stiffness of the scaffold can range from 4–80 MPa, depending on the lay-down pattern, 
fiber thickness, and the polymers used for fabrication [38]. Using a 0/45º lay-down pattern, the 
compressive stiffness in the z plane is different compared to the compressive stiffness in the x/y plane, 
thereby resulting in mechanical anisotropy. Anatomically 3D fiber deposited trachea, menisci and 
vertebra have recently been fabricated from patient-derived computer-based medical imaging 
modalities [25,35,40]. In addition, shell/core fibers have been produced by exploiting viscous 
encapsulation, a rheological phenomenon in polymeric blends flowing through narrow ducts [41]. 
Furthermore, by printing fibers directly aligned in one layer followed by a semi-open layer, anisotropic 
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scaffolds with aligned channels can be created (unpublished data). In this way, also nutrient supply in 
the deeper zones of the scaffolds could be facilitated [42]. 
Figure 1. (A) Schematic representation of 3D fiber deposition (3DF)/Fused deposition 
modeling (FDM). (B) SEM micrographs of a PCL scaffold with varying multiple-layer 
design prepared using 3DF/FDM, showing a scaffold architecture with (A) a 0/60/120° lay-
down pattern for the top part, (B) a nonporous structure for the middle part, and (C) a 0/90° 
lay-down pattern of the bottom part of the scaffold. Reproduced and modified with 
permission from Hutmacher et al. [99]. Copyright John Wiley & Sons, Inc. (C) Schematic 
representation of stereolithography (STL). (D) SEM micrographs of a STL prepared 
scaffold, showing (A) a single-layer scaffold, and (B) a multilayered scaffold. Reproduced 
and modified with permission from Mapili et al. [59]. Copyright John Wiley & Sons, Inc. 
(E) Schematic representation of modified thermal induced phased separation (TIPS). (F) 
SEM micrographs of the uniaxial microtubular scaffolds prepared using modified TIPS, 
showing (A) a cross-section of a scaffold prepared from 2.5% (w/v) polymer/benzene 
under liquid nitrogen, (B) a longitudinal section of this scaffold, (C) a cross-section of a 
scaffold prepared from 3.0% (w/v) polymer/benzene under liquid nitrogen, and (D) a 
longitudinal section of this scaffold. Reproduced and modified with permission from Chen 
et al. [72]. Copyright John Wiley & Sons, Inc. (G) Schematic representation of modified 
electrospinning. (H) SEM micrographs of scaffolds prepared with electrospinning, 
showing (A-C) aligned nanofibers, and (D) uniaxially aligned nanotubes. Reproduced and 
modified with permission from Li et al. [100]. Copyright Wiley-VCH Verlag GmbH & Co. 
KGaA. 
A               B  
C   D  
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2.2. Bioplotter 
Bioplotting was first described by Wilson and Boland [43]. They modified a commercial inkjet 
printer into a custom-made bioplotter. After cleaning the ink cartridges, the containers were refilled 
with solutions containing marker proteins (y-biotine, steptavidine, streptavidine-BSA and BSA) or 
with endothelial or smooth muscle cells. The resolution of this technique has been shown to be 
approximately 25-50 µm in both the x and y directions [43,44]. Using this technique, complex 
structures containing viable cells after printing have been produced [45]. However, after printing a 
25% cell death was observed [43]. It has been shown that cell death could be strongly reduced by 
avoiding dehydration of the cells after printing by increasing the water content of the gels in which the 
cells are encapsulated [43,46,47]. Incorporation of growth factors or other biological cues, such as 
calcium phosphates, specific adhesive peptides, and collagen can modulate cell function and 
degradation of the scaffold [34]. In this way, an instructive microenvironment for embedded or seeded 
cells can be created [48]. Cohen et al. were able to fabricate a geometrically complex structure in the 
shape of a meniscus using alginate as scaffold material [44]. However, so far, no anisotropic scaffolds 
have been fabricated using bioplotting. Using multiple cartridges, zonal distribution of multiple cell 
types and biological cues anisotropic scaffolds should be relatively easily achieved [34]. 
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2.3. Stereolithography 
Stereolithography is the oldest RP technique [49]. It is based on spatially controlled 
photopolymerization of a liquid resin by a laser. As the resin only solidifies where illuminated, a 
specific pattern can be created in one single layer. By repeating this process, three-dimensional 
structures can be built in a layer-by-layer manner (Figure 1CD) [50,51]. In conventional STL machines 
one laser beam is used for photopolymerization. However, recently new systems have been developed 
which use two lasers in the near infrared spectrum, the so-called two photon polymerization technique 
(2PP) [52-55]. 
A prerequisite for polymers to be used in STL are end-groups that can be polymerized by light 
[3,50,54-60]. Epoxy resins are very popular for the generation of non-resorbable STL molds. These 
molds are used to shape polymers into conventional made scaffolds for various tissue engineering or 
regenerative medicine purposes [61-63]. Two resorbable materials are particularly interesting for STL 
scaffold production. First, scaffolds based on poly-DL-lactic acid (PDLLA) are very popular for bone 
tissue engineering. A second very promising material that has been recently introduced is 
poly(propylene fumarate) (PPF) [64,65]. Hydrolysis of the ester bonds allows PPF to degrade into 
fumaric acid and propylene glycol, both of which are non-toxic products [55]. Scaffolds made from 
PFF have mechanical properties in the MPa range (15-40 MPa) and are also suitable for bone tissue 
engineering. 
The accuracy of STL is dependent on a number of parameters. The most important ones are the 
machine, the method (one photon versus two photon polymerization) [49,53,54], the laser power 
[53,65], the scan speed [65], and the length of the laser beam path into the polymer [66]. In general, 
commercial STL machines have a resolution in the order of 200–250 µm. Some claim a resolution of 
75 µm or even lower but then they might fail to create open pores [59]. Others claim even accuracies 
of 10–100 µm, however this has been shown to be the ultimate limit of accuracy with conventional 
machines [54]. The penetration depth, and by that the accuracy in the z-direction, may be increased by 
adding specific dyes to the polymer which reduce the penetration depth of the UV beam. With 
conventional STL the layer thickness can then be reduced from 29 to 7 µm [66]. The structural resolution 
of 2PP polymerization is in general much higher and can be even lower than 100 nm [53,54]. 
A matter of attention is the matching between CAD files and the produced scaffold structures. 
Shrinkage of resins used for STL is a general phenomenon and might be up to 25% [64,65]. However, 
if the shrinkage is isotropic, which is generally the case, the CAD files might be adapted to the 
expected percentage of shrinkage of a specific polymer with a good matching as a result [3,65]. 
Generally, the difference between the CAD file and the produced structure will not exceed 0.5%. For 
porous scaffolds the differences between CAD files and the produced pores have been described to be 
larger, ranging from 0.2% for the large pores to 8.3% for the very small pores [65]. 
Amongst the pitfalls in STL are diluting the polymers before the polymerization process and the use 
of non-reacted chemicals after polymerization [66]. Diluting the polymers negatively influences the 
mechanical properties of the produced structures [67]. Non-reacted chemicals inside the scaffold can 
potentially cause problems if they are not adequately removed from the fabricated structures. 
Particularly non-reacted photo-initiator might be cytotoxic [68]. The use of biocompatible non-reacted 
polymers and non-reactive diluents would be a solution [66]. 
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Functional studies on STL scaffolds are scarce. Engelmayer et al. have shown that pore dimensions 
influence collagen orientation and deposition by rat skin fibroblasts [69]. Using 2PP STL, sub-micron 
needle like structures have been produced on which the reaction of fibroblast cells (NIH-3T3) and 
epithelial cells (MDCK) has been shown to be dependent on the pattern of actin microfilament bundles 
in the cells. For bone TE scaffolds with channels were produced to study the optimal channel diameter 
to facilitate cell ingrowth [70]. Functional animal studies related to the in-vivo tissue reactions are very 
scarce. The group of Jansen studied the soft and hard tissue response to photo-crosslinked PPF 
scaffolds in a rabbit model [58]. These scaffolds appeared to induce a mild inflammatory reaction in 
both tissue types. A powerful future application might be the blending of cells into SLT scaffolds 
during photopolymerization [56]. 
3. Modified Conventional Techniques 
Conventional methods for manufacturing scaffolds include particle leaching [9,10], gas (CO2) 
foaming [11], freeze-drying [12], thermal induced phase separation (TIPS) [13,14], liquid/liquid phase 
separation in combination with freeze extraction [15], electrospinning [16], and particle sintering 
[17,18]. However, there are inherent limitations in these processing methods. These methods offer 
little capability to control pore size, pore geometry, pore interconnectivity, spatial distribution of pores 
and construction of internal channels within the scaffold.[71]. Consequently, it has been tried to 
modify the conventional techniques to overcome these inherent process limitations [17,72-75]. The 
following sections will focus on modified conventional techniques that have been used to fabricate 
anisotropic scaffolds. 
3.1. Modified Thermal Induced Phase Separation (TIPS) 
A commonly used procedure to create porous polymer scaffolds is TIPS. This technique is based on 
the principle that a homogeneous polymer solution made at elevated temperature is converted via the 
removal of thermal energy (cooling) into two-phase separated domains. Through extraction, 
evaporation or sublimation the solvent containing phase will be removed and give rise to the pores of 
the scaffold. Two different phase separations have been described, namely solid-liquid and liquid-
liquid phase separation. In solid-liquid phase separation the temperature is lowered to solidify the 
polymer solution. The solvent will form crystals and thereby separate the polymer from the solvent. 
Finally, the crystals are removed which exposes the pores. In the second method, liquid-liquid phase 
separation, phase separation is based on a polymer-rich and a polymer-lean phase. The solvent part 
will be present in the polymer lean phase which will be processed further to create the pores in the 
scaffold [14,76]. For example, polymers such as PLA and PLGA are diluted in dioxane/water in the 
desired polymer concentration and subsequently cooling down of the polymer induces the phase 
separation. A porous foam-like scaffold is available after removal of the solvent in a freeze-dryer. The 
formed scaffolds have a randomly distributed isotropic pore structure [77-79]. 
In the modified TIPS a uni-axial thermal gradient is applied between top and bottom instead of 
uniformly cooling during the phase separation step (Figure 1EF) [80]. Via insulation of the walls of the 
polymer/solvent container a longitudinal temperature gradient is created resulting in longitudinal 
crystal formation. The result is a scaffold containing micro-channels instead of pores, which are 
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orientated in a top to bottom direction. The diameter of these micro-channels can range between  
15–240 µm [72,81,82]. The diameter can be controlled by changing the thermal gradient and/or the 
proportion polymer/solvent. Using a higher thermal gradient and higher polymer concentration the 
diameter of the channels has been shown to decrease. The micro-architecture of the channels can be 
influenced by the type of solvent used. Using benzene as a solvent, microtubules will be open, while 
with dioxane the channels have ladder-like structures [72,80]. The anisotropic structural properties of 
the scaffold is reflected in higher compressive modulus and yield strength in the longitudinal direction 
compared to the transverse direction [72,80]. Culture studies show that cells grow along the direction 
of the microtubules and synthesize oriented neo-tissue [83]. Modified TIPS has also been applied to 
natural polymers such as collagen. A temperature gradient between bottom and top of the container, 
according to the Bridgman technique [84], resulted in an ice front growth in an opposite direction than 
the temperature gradient [85]. Applying this temperature gradient to collagen suspensions resulted in 
unidirectional collagen scaffolds, also with some ladder-like characteristics [86-88]. The channels 
were in the range 20-40 µm and were predominantly controlled by the temperature gradient and 
solvent type (either ethanol or acetic acid). The scaffolds can be molded in discs or tube like shapes. It 
should be noticed that after polymerization skin formation can occur on the edge, thereby limiting cell 
penetration into the scaffold. 
3.2. Electrospinning 
A conventional method for fiber deposition is electrospinning. Using a high voltage/low current a 
very thin fiber (tenths of nanometers) can be produced from a polymer droplet, which is directed 
toward a grounded counter plate electrode, the so-called collector plate. On a static collector plate the 
fibers will be displayed in a random orientation. Scaffolds can be fabricated in various different 
tubular configurations with different surface patterning using different shaped, static 3D, columnar 
patterned collectors [89]. With help of a rotating cylinder or rotating disc type collector it is possible to 
produce orientated/aligned fibers (Figure 1GH) [90,91]. It has been shown that fiber diameter and 
degree of fiber alignment can determine the behavior of cells [16]. Cells orientate themselves and 
migrate into the direction of the fiber orientation with higher proliferation and synthetic rates [92,93]. 
Aligned nanofibers seeded with ligament fibroblasts induced more elongated fibroblasts compared to 
randomly orientated fibers, and these cells also produced more collagen compared to cells on  
non-aligned scaffolds [94]. Multiple spinneret tips with different polymers can create multilayer 
scaffolds [95]. These layers can also be separated by seeded cells. Using different cell types in between 
layers, complex 3D structures with living cells have been produced [96]. With a set-up using a syringe-
inside-a-syringe core/shell nanofibers have been created [97]. This technique is has also been used to 
produce aligned collagen nanofiber scaffolds with a similar cellular response to fiber orientation as 
described above [98]. 
4. Alternative Methods to Create Anisotropic Scaffolds 
Using the techniques outlined above, the production of aligned channels in a scaffold has been 
realized. However, most of the above mentioned techniques are technically demanding. Alternative 
methods might be cheaper, more easy to use, or useful if the size of features in the scaffolds is limited 
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by the resolution of the technique. Therefore, a number of alternative methods have been proposed to 
incorporate aligned channels into the general structure of the scaffold. Some of these alternative 
methods can be applied directly during scaffold polymerization, while others are applied after 
polymerization as a post-processing step. 
4.1. Direct Methods 
Most polymers are in the liquid phase before molding. Using arrays of needles and/or wires placed 
in the mold, porous scaffolds with aligned channels can easily be fabricated. The diameter of these 
channels depends on the thickness of the needles and/or wires used. The architecture can vary on the 
needle array applied [101,102]. Unfortunately, removal of the needles and/or wires after 
polymerization has been shown to damage these scaffolds. To prevent damage, coated wires and/or 
needles have been used [103]. After polymerization of the scaffold, the coating on the wires or needles 
can be dissolved, facilitating the removal of the wires and/or needles. An alternative approach is to use 
wires that can dissolve completely [18,103]. Nazhat et al. incorporated unidirectional aligned soluble 
30–40 µm diameter phosphate glass fibers (PGFs) into dense compacted collagen scaffolds [104]. The 
degradation time of PGFs can range from minutes to years depending on their chemistry. Their 
biocompatibility has been demonstrated with a number of cell types [105,106]. In addition, the use of 
phosphate glass particles as reinforcing agents, and eventually as porogens through their degradation 
in synthetic biodegradable composites, has been carried out in PCL [107,108] and lactide [109,110] 
matrices developed for drug delivery and tissue engineering. Therefore, PGFs might also be used as 
channel-creating devices in synthetic biodegradable composites. Besides solvable wires or retracting 
wires, it is also possible to leave the wires inside the scaffold but then the effect of creating access for 
mass transport is lost [111]. 
Another direct method to create anisotropic scaffolds is the use of conventional porogens, such as 
sugar, salt, alginate, or bovine serum albumin micro-bubbles [112–115]. Capes et al. have managed to 
arrange sugar strands in a mold [116]. Subsequently, the polymer solution was casted over the sugar 
strands, and after polymerization the strands were washed out. Similar methods can be applied using 
other porogens like paraffin, sodium alginate and/or gelatine [117]. 
4.2. Post-Processing Methods 
Various methods have been described to create channels in scaffolds after polymerization. Silva et 
al. produced an array of aligned 400 µm thick channels into a random, porous PDLLA scaffold 
structures using a computer controlled drill system [102]. Using relatively thin polymer sheet, excimer 
laser ablation has been used to create specifically sized channels in polymer scaffolds [118–121]. For 
musculoskeletal tissue engineering purposes stacking these single-layer sheets might be an option. 
Recently, Vishnubhatla et al. have fabricated micro-channels in fused silica by femto-second laser 
irradiation [122]. They have created cylindrical micro-channels with uniform cross-sections and a 
length of 4 mm. As mentioned above, Capes et al. used a traditional solid porogen technique for the 
fabrication of PGLA scaffolds [116]. Besides the use of close-packed sugar strands to create a 3D 
polymer scaffold with multiple aligned channels, they also created single-layer scaffolds using sugar 
spheres. Multi-layer scaffolds were created by stacking the single-layer to form a 3D structure. Also 
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known porogens such as, paraffin, sodium alginate, and gelatine might be used to create anisotropic 
scaffolds using single-layer stacking. Using phase separation micromolding, Papenburg et al. reported 
a one-step method to fabricate highly porous micro-patterned polymer 2D scaffold sheets [123]. These 
2-D micropatterned sheets can be built into a 3-D scaffold by multi-layer stacking immediately after 
casting. Residues of the solvent still present in the sheets enabling the layers to bond. Stacking was 
achieved through two different methods: by either clamping several films between glass-plates or 
rolling up one or more sheets around a tube. By tuning the size of the channels and the sheet thickness, 
the scaffold architecture can be designed. 
5. Discussion 
Tissue engineered biomaterials should ideally bear close resemblance to the in vivo mechanical and 
structural properties of the tissues that they are intended to replace. Since mechanical loads can vary 
spatially and temporally within the tissues of an organ, they exhibit complex, mechanically anisotropic 
behaviors optimized for their respective physiological functions [124]. 
Many tissues in the musculoskeletal system, particularly those that bear mechanical loads in a 
defined direction, exhibit preferential fiber alignment [125]. This alignment endows such tissues to 
functional properties that vary depending on the testing direction. For example, in tendons and 
ligaments, tensile properties are 200-500 times higher along, compared to perpendicular to, the fiber 
direction [126]. In articular cartilage, tensile properties are greatest in the superficial zone along the 
split line direction [127,128]. In the meniscus, circumferentially oriented collagen fibers predominate 
[129], resulting in higher tensile properties in the circumferential compared to the radial direction 
[130–132]. When damage occurs, the architecture is interrupted and the ability of the tissue to 
withstand load is compromised. As such, the architecture must be one of the first considerations when 
engineering replacement constructs [133].  
Using conventional scaffolds, it has been shown that the tissues formed had no relationship with the 
native tissue but were oriented into the direction of the isotropic distributed pores [23]. Differentiation 
of the newly formed tissue directly into the anisotropic organization of the native tissue would be 
much more efficacious. Therefore, one of the considerable challenges remaining in the field of tissue 
engineering is to produce a construct with an anatomically correct architectural framework, both in 
terms of cell morphology and matrix deposition [125]. 
The use of SFF techniques will allow control over localized pore morphologies and porosities to 
suit the requirements of different cell types within the same scaffold volume. This is achieved by 
incorporating different controllable macroscopic and microscopic design features on different regions 
of the same scaffold. Depending on the TE strategy used, this can be realized either using negative 
anisotropic scaffolds, positive anisotropic scaffolds, or a combination of both. Negative anisotropic 
scaffolds, often referred to as “mirror imaged” scaffolds, are fabricated based on guidance or 
entubulization TE strategies. Newly formed tissues growing into the scaffold will be guided and 
subsequentially differentiate directly into the anisotropic organization of the native tissues (indirect) 
[72,80,82,83,88,103]. On the other hand, positive anisotropic constructs are fabricated directly into the 
anisotropic organization of the native tissue, resembling the hierarchical structure of multiple cell 
types, and/or ECM compounds, such as collagen and elastin [34,45,96,134]. Scaffolds consisting of 
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aligned fibers were found to possess controllable anisotropic mechanical properties and to dictate 
cellular morphology, with cell polarity following the prevailing fiber direction [125]. Under conditions 
of maximal fiber alignment, meniscal chondrocytes attached to these scaffolds and their directionality 
was prescribed in both the short and long term culture. It has previously been shown in organized 
monolayer cultures that fibroblasts deposit an organized ECM according to cell orientation [135], and 
that ligament fibroblasts on an aligned fiber meshes produce more collagen than on random  
meshes [94]. 
A common problem encountered when using conventional scaffolds for tissue engineering is the 
rapid formation of tissue on the outer edge, leading to the development of a necrotic core due to 
limitations of cell penetration and nutrient exchange [102,136,137]. Most tissues possess a network of 
blood and capillary vessels that perform this function in vivo, but engineering such a complex 
construct in vitro has been shown to be quite challenging [138,139]. Even avascular tissue, such as 
cartilage, has been shown challenging to engineer since the in vivo nutrient supply still cannot be 
adequately simulated in vitro [136]. A common approach used to overcome this issue is to utilize 
sophisticated culture systems or bioreactors to perfuse culture media around and/or through the 
scaffold [140-142]. Although these bioreactors have been successful, even in an optimized in vitro 
culture system, there is still a need to ensure tissue growth occurs evenly throughout the construct. 
Furthermore, for strategies where the scaffold alone will be implanted and the body is used as 
bioreactor, it is important to ensure that native tissue can infiltrate the whole scaffold to ensure 
adequate integration of the construct [143]. Another strategy to encourage tissue formation and cell 
differentiation within scaffolds, in vitro or in vivo, is to incorporate biological factors, such as growth 
factors, ECM compounds, or pharmaceutical agents which can also act as chemotactic factors to 
encourage cell migration and differentiation [144]. 
Patient specific data and scaffold structural properties required for regenerating specific tissues can 
be incorporated into scaffold design via CAD, often referred to as ‘reverse engineering’ [22]. SFF 
techniques can be easily automated and integrated with these imaging techniques to produce scaffolds 
that are customized in size and shape allowing tissue engineered grafts to be tailored for specific 
applications or even for individual patients [145]. In musculoskeletal applications, so far, these patient 
specific scaffolds have been used for the reconstruction of cranial [146,147], calvarial [148], and 
maxillofacial defects [149]. 
A key factor used to enhance the versatility of scaffold fabrication by SFF is construction of a 
scaffold matrix using a wide variety of biomaterials [145]. One emerging method is to fabricate a 
negative mold based on the scaffold design and cast the scaffold using desired polymeric and/or 
ceramic biomaterials. This alternative technique is known as ‘indirect’ SFF. Based on a lost mold 
technique by combining epoxy resin molds made by stereolithography and CAD data HA scaffolds 
with interconnecting pores have been created [150]. Despite a few fabrication inaccuracies, in-vivo 
experiments demonstrated osteoconductivity and biocompatibility in a minipig model. In addition, a 
series of biomimetic scaffolds have been fabricated by mold removal in combination with conventional 
sponge fabrication [151]. The fabricated scaffolds had interconnected pores ranging from 500–800 µm 
as specified by the prefabricated mold, and when local pores were formed they ranged from 10–300 
µm depending on the local pore creating method. Similarly, an indirect SFF method for ceramic 
scaffolds with a defined and reproducible 3D porous architecture has been developed [152]. They 
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reported ectopic bone formation for all scaffold and cell constructs. Manufacturing of collagen based 
scaffolds by using the SFF technique to fabricate a mold has also been reported [153]. 
The main restriction on casting with the conventional techniques was the inability to create molds 
to produce complex geometries and internal architecture but with indirect SFF conventional casting 
processes with these molds can meet specific tissue engineering requirements [145]. Indirect SFF 
allows use of a wider range of biomaterials or combinations of materials, such as composites and/or 
copolymers. However, some drawbacks still exist with this technology, including the use of organic 
solvents and the resolution of the SFF method. For example, the cast model copies errors and defects 
from the mold, such as cracks and dimensional changes. In addition, a method has to be developed to 
remove the mold precisely while preserving the cast scaffold intact without compromising its 
properties [145]. 
6. Conclusions 
Although many options are available to fabricate anisotropic scaffolds for musculoskeletal tissue 
engineering, each method has its own set of strengths and weaknesses. For all techniques described, 
the choice of scaffold material seems to be endless since almost every polymer, natural or synthetic, 
can be used in combination with the desired technique. However, it has to be ensured that choice of 
materials for the scaffold is compatible with the selected method. Important considerations that should 
be made during the selection of materials used for musculoskeletal tissue engineering include 
mechanical properties of the material, scaffold design, degradation profile, bioactivity and 
biodegradability, as well as issues of cell seeding and vascularization. 
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